Sign Up to like & get
recommendations!
0
Published in 2018 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-018-2583-5
Abstract: PurposeThe purpose of this study was to analyze the association between bleeding events and coagulation assays including activated partial thromboplastin time (APTT) and prothrombin time (PT), and to determine the risk factors for bleeding in…
read more here.
Keywords:
risk;
nvaf patients;
bleeding events;
age ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0038-1676818
Abstract: BACKGROUND  There have been no prior nationwide reports on the prevalence of hypertrophic cardiomyopathy (HCM) among patients suffering from atrial fibrillation (AF). It is also unclear how much stroke risk is attributable to HCM compared…
read more here.
Keywords:
nvaf patients;
stroke risk;
prevalence;
hcm ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz745.0657
Abstract: Poorly controlled non-valvular atrial fibrillation (NVAF) patients treated with vitamin K antagonists (VKA) experience higher rates of clinical events compared to well controlled patients. In Spain a high percentage of NVAF patients present an inadequate…
read more here.
Keywords:
anticoagulation;
nvaf patients;
control;
clinical events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-111182
Abstract: Background Direct oral anticoagulants (DOACs) are at least as effective as vitamin K antagonists (VKAs) for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). DOACs are associated with less intracranial hemorrhage and are easier…
read more here.
Keywords:
therapy;
nvaf patients;
doac therapy;
mortality ... See more keywords